<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>TST_H</title>
    <meta name="title" content="NHANES 2013-2014: Sex Steroid Hormone - Serum Data Documentation, Codebook, and Frequencies" />
    <link rel="stylesheet" href="https://wwwn.cdc.gov/nchs/nhanes/css/documentation.css" />
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#LBXTST">LBXTST - Testosterone, total (ng/dL)</a>
              </li>
              <li>
                <a href="#LBDTSTLC">LBDTSTLC - Testosterone comment code</a>
              </li>
              <li>
                <a href="#LBXEST">LBXEST - Estradiol (pg/mL)</a>
              </li>
              <li>
                <a href="#LBDESTLC">LBDESTLC - Estradiol Comment Code</a>
              </li>
              <li>
                <a href="#LBXSHBG">LBXSHBG - SHBG (nmol/L)</a>
              </li>
              <li>
                <a href="#LBDSHGLC">LBDSHGLC - SHBG Comment Code</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2013-2014 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Sex Steroid Hormone - Serum (TST_H)</h3>
        <h4> Data File: TST_H.xpt</h4>
        <h5 class="left">First Published: November 2018</h5>
        <h5 class="right">Last Revised: NA</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">This data will allow for population estimates of the selected steroid hormones and related binding protein that can be used to assist in disease diagnosis, treatment, and prevention of diseases such as, Polycystic Ovary Syndrome (PCOS), androgen deficiency, cancer, and hormone imbalances in children. An estimated 5 to 7 million women in the United States (U.S) suffer with the effects of PCOS. It is the most common hormonal disorder among women of reproductive age, which can occur as young as 11 years old, and is the leading cause of infertility. Androgen deficiency such as hypogonadism is associated with a range of chronic diseases. The prevalence of symptomatic androgen deficiency in men between 30 and 79 years of age is estimated to be 5.6% (Araujo et al, 2007). Androgen deficiency in men and excess in women and the associated chronic diseases are a public health concern. Estradiol is the key biomarker for assessing reproductive function in females, including amenorrhea, infertility, and menopausal status. Estradiol levels decline greatly with age, and this decrease is associated with increased risk for cardiovascular disease, cognitive impairment, and bone fractures in older populations. Estrogen hormone therapy, or use of estradiol as a supplement, raises health concerns related to estradiol concentration in blood such as elevated levels in postmenopausal women increasing the risk of breast cancer.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><b>Testosterone</b> </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Testosterone is
the most important androgenic steroid that has an anabolic effect
in humans. It is synthesized in the testes of
the male, and in much smaller amounts, in the ovary of the female, and in the
adrenal gland of both female and male.&nbsp; In
male humans, testosterone plays a key role in the development of male reproductive tissues, such as the testis and prostate, as well as promoting secondary sexual characteristics such as increased muscle and bone mass, and the growth of body hair.&nbsp; The secretion of testosterone is regulated by
luteinizing hormone (LH), and is subject to negative feedback via the pituitary
and hypothalamus.&nbsp; Most of the
circulating testosterone is bound to carrier proteins (sex hormone-binding
globulin [SHBG], and albumin). In women, increased production of testosterone can
cause hirsutism and virilization (depending on increase).&nbsp; The determination of testosterone in the
female is helpful in the evaluation of congenital adrenal hyperplasia, PCOS, and
when an ovarian tumor, adrenal tumor, adrenal hyperplasia or ovarian
insufficiency is suspected. Testosterone is determined in men when reduced
testosterone production is suspected, e.g. in hypogonadism, estrogen therapy,
chromosome aberrations (as in the Klinefelter&rsquo;s syndrome) and liver cirrhosis.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><b>Sex
hormone-binding globulin (SHBG)</b></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Sex
hormone-binding globulin (SHBG) is the blood transport protein for androgens and
estrogens. &nbsp;SHBG has a high binding
affinity to dihydrotestosterone (DHT), medium affinity to testosterone and
estradiol, and only a low affinity to estrone, dehydroepiandrosterone (DHEA),
androstendione, and estriol. Albumin, which exists in far higher concentrations
than SHBG, also binds sexual steroids &ndash; although with a clearly lower binding
affinity (e.g. about 100 times lower for testosterone). Its synthesis and
secretion are regulated by estrogen (Burger, et al. 2002; Davis, et al. 2001).
SHBG serum concentrations depend on the extent, duration, and the kind of
estrogen applied, and how regulation takes place. In the serum SHBG mainly
takes over the transportation of steroids and the reduction/regulation of the
effect of androgen. (Rosner, et al. 1999; Burger, et al. 2002). Decreased SHBG
serum levels are associated with conditions where elevated androgen levels are
present or where the effect of androgen on its target organs is excessive. This
explains the gender-related differences seen between men and women, especially
during puberty.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Measurement of
SHBG can be an important indicator of an excessive/chronic androgenic action
where androgen levels are normal, but where clinical symptoms would seem to
indicate androgen in excess. SHBG is a useful supplementary parameter in the
determination of androgen where a relatively high concentration of free
androgen (e.g. testosterone) is suspected (Pugeat, et al. 1996). </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Elevated SHBG
levels can be seen in elderly men, and are often found in patients with hyperthyroidism,
cirrhosis of the liver, and some polymorphisms in the SHBG gene (Bhasin, et al
2018). SHBG levels also increase when oral contraceptives, estrogen or
antiepileptic drugs are taken. Pregnant women have markedly higher SHBG serum
concentrations due to their increased estrogen production. </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Decreased SHBG
concentrations are often seen with hypothyroidism, polycystic ovarian syndrome
(PCOS), obesity, hirsutism, elevated androgen levels, alopecia, acromegaly and
some polymorphisms on the SHBG gene.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><b>Estrogens&nbsp;</b></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Estrogens are
responsible for the development of the secondary female sex characteristics.
Together with progestogens they control all the important female reproductive
processes. The biologically most active estrogen is 17 &szlig;-estradiol. Estrogens
are produced primarily in the ovary (follicle, corpus luteum), but small
quantities are also formed in the testes and in the adrenal cortex, as well as
fat cells. During pregnancy, estrogens are mainly formed in the placenta. About
98% of estradiol is bound to transport proteins (SHBG and albumin). Estrogen
secretion has two surges during the menstrual cycle. The determination of
estradiol is utilized clinically in the elucidation of fertility disorders in
the hypothalamus-pituitary-gonad axis, gynecomastia, estrogen-producing ovarian
and testicular tumors and in hyperplasia of the adrenal cortex. Further clinical
indications are the monitoring of fertility therapy and determining the time of
ovulation within the framework of in vitro fertilization (IVF).<span><br />
</span></p><h2 id="Eligible_Sample">Eligible Sample</h2><p>Examined participants aged 6 years and older.</p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Measurements of total testosterone and estradiol in serum are performed using isotope dilution liquid chromatography tandem mass spectrometry (ID-LC-MS/MS) method for routine analysis developed by CDC. The method was created for high sample throughput and demonstrates high accuracy and precision over multiple years. It is certified by CDC Hormone Standardization Program (HoSt) and is traceable to certified reference materials obtained from Australian National Measurement Institute, ANMI M914, Australian for testosterone (Zhou, et al, 2017).</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">SHBG is based on the reaction of SHBG with immuno-antibodies and chemo-luminescence measurements of the reaction products
that occurs after two incubation periods and subjecting to a magnetic
field.&nbsp; The microparticle are captured on
an electrode, where a chemiluminescent reaction occurs and can be measured by a
photomultiplier tube. The readings are compared to an instrument- and
lot-specific calibration curve.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Refer to the
Laboratory Method Files section for detailed description on
the laboratory
methods used. </p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2013/labmethods/TST_H_MET_Total_Testosterone.pdf">Total Testosterone</a>
          <span> (November 2018)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2013/labmethods/TST_H_MET_Sex_Hormone_Binding_Globulin.pdf">Sex Hormone-Binding Globulin</a>
          <span> (November 2018)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2013/labmethods/TST_H_MET_Total_Estradiol_and_Total_Testosterone.pdf">Total Estradiol and Total Testosterone</a>
          <span> (November 2018)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Serum samples are
processed, stored, and shipped to the Division of Laboratory Sciences, National
Center for Environmental Health, Centers for Disease Control and Prevention,
Atlanta, GA for analysis.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Detailed
instructions on specimen collection and processing are discussed in the NHANES <a href="http://www.cdc.gov/nchs/data/nhanes/nhanes_13_14/2013_MEC_Laboratory_Procedures_Manual.pdf">Laboratory
Procedures Manual (LPM)</a>. Vials are stored under appropriate frozen
(&ndash;20&deg;C) conditions until they are shipped to the&nbsp;National Center for Environmental
Health for testing.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The NHANES quality
assurance and quality control (QA/QC) protocols meet the 1988 Clinical
Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed
in the NHANES <a href="http://www.cdc.gov/nchs/data/nhanes/nhanes_13_14/2013_MEC_Laboratory_Procedures_Manual.pdf">LPM</a>.
</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><strong>Mobile Examination
Centers (MECs)</strong></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Laboratory team
performance is monitored using several techniques. NCHS and contract
consultants use a structured quality assurance evaluation during unscheduled
visits to evaluate both the quality of the laboratory work and the
quality-control procedures. Each laboratory staff member is observed for
equipment operation, specimen collection and preparation; testing procedures
and constructive feedback are given to each staff member. Formal retraining
sessions are conducted annually to ensure that required skill levels were
maintained.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><strong>Analytical
Laboratories</strong></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">NHANES uses
several methods to monitor the quality of the analyses performed by the
contract laboratories. In the MEC, these methods include performing blind split
samples collected&nbsp;during &ldquo;dry run&rdquo; sessions. In addition, contract
laboratories randomly perform repeat testing on 2% of all specimens.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">NCHS developed and
distributed a quality control protocol for all the contract laboratories, which
outlined the use of Westgard rules (Westgard, et al. 1981) when running NHANES
specimens. Progress reports containing any problems encountered during shipping
or receipt of specimens, summary statistics for each control pool, QC graphs,
instrument calibration, reagents, and any special considerations are submitted
to NCHS quarterly. The reports are reviewed for trends or shifts in the data.
The laboratories are required to explain any identified areas of concern.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">All QC procedures
recommended by the manufacturers were followed. Reported results for all assays
meet the Division of Environmental Health Laboratory Sciences&rsquo; quality control
and quality assurance performance criteria for accuracy and precision, similar
to the Westgard rules (Caudill, et al. 2008). </p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The data were reviewed.  Incomplete data or improbable values were sent to the performing laboratory for confirmation.</p><h2 id="Analytic_Notes">Analytic Notes</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Refer to the 2013-2014 <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2013">Laboratory Data Overview</a> for general information on NHANES Laboratory Data.</p>
<p><strong>NHANES Demographic and Other Related Variables</strong></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The analysis of NHANES laboratory data must be conducted using the appropriate survey design and demographic variables. The <a href="https://wwwn.cdc.gov/nchs/nhanes/2013-2014/demo_h.htm">NHANES 2013-2014 Demographics File</a> contains demographic data, health indicators, and other related information collected during household interviews as well as the sample design variables. The recommended procedure for variance estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively) in the demographic data file.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The <a href="https://wwwn.cdc.gov/nchs/nhanes/2013-2014/fastqx_h.htm">Fasting Questionnaire File</a> includes auxiliary information such as fasting status, the time of venipuncture, and the conditions precluding venipuncture.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">This laboratory data file can be linked to the other NHANES data files using the unique survey participant identifier (i.e., SEQN).</p>
<p><strong>Detection Limits</strong></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The detection
limits were constant for all of the analytes in the data set. Two variables are
provided for each of these analytes. The variable named ended &ldquo;LC&rdquo; (ex., LBATSTLC)
indicates whether the result was below the limit of detection: the value &ldquo;0&rdquo;
means that the result was at or above the limit of detection, &ldquo;1&rdquo; indicates
that the result was below the limit of detection. The other variable prefixed LBX
(ex., LBXTST) provides the analytic result for that analyte. For analytes with
analytic results below the lower limit of detection (ex., LBDTSTLC=1), an
imputed fill value was placed in the analyte results field. This value is the
lower limit of detection divided by the square root of 2 (LLOD/sqrt[2]). </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The lower limit of
detection (LLOD) for LBXTST, LBXEST and LBXSHBG are:</p>
<table width="0" style="margin: auto auto auto 53.6pt; border: currentColor; border-image: none; width: 330.65pt; border-collapse: collapse; mso-border-alt: solid black .75pt; mso-yfti-tbllook: 1184; mso-padding-alt: 1.5pt 1.5pt 1.5pt 1.5pt;" border="1" cellspacing="0" cellpadding="0">
    <thead>
        <tr style="height: 24.9pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes;">
            <td valign="top" style="background: #f4f4e1; padding: 3.75pt; border: 1pt solid black; border-image: none; height: 24.9pt; mso-border-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; text-align: center; line-height: normal;"><b>Variable
            Name&nbsp;</b></p>
            </td>
            <td valign="top" style="background: #f4f4e1; border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: black black black #000000; padding: 3.75pt; border-image: none; height: 24.9pt; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; text-align: center; line-height: normal;"><b>SAS
            Label&nbsp;</b></p>
            </td>
            <td valign="top" style="background: #f4f4e1; border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: black black black #000000; padding: 3.75pt; border-image: none; width: 89pt; height: 24.9pt; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; text-align: center; line-height: normal;"><b>&nbsp;LLOD</b></p>
            </td>
        </tr>
    </thead>
    <tbody>
        <tr style="height: 24.15pt; mso-yfti-irow: 1;">
            <td valign="top" style="border-width: 0px 1pt 1pt; border-style: none solid solid; border-color: #000000 black black; padding: 3.75pt; border-image: none; height: 24.15pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">LBXTST</p>
            </td>
            <td valign="top" style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; height: 24.15pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">Testosterone, total (ng/dL)</p>
            </td>
            <td valign="top" style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; width: 89pt; height: 24.15pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">0.75 ng/mL*</p>
            </td>
        </tr>
        <tr style="height: 24.9pt; mso-yfti-irow: 2;">
            <td valign="top" style="border-width: 0px 1pt 1pt; border-style: none solid solid; border-color: #000000 black black; padding: 3.75pt; border-image: none; height: 24.9pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">LBXEST</p>
            </td>
            <td valign="top" style="padding: 3.75pt; border: 0px #000000; border-image: none; height: 24.9pt; background-color: transparent;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">Estradiol (pg/mL)</p>
            </td>
            <td valign="top" style="border-width: 0px 1pt 1pt; border-style: none solid solid; border-color: #000000 black black; padding: 3.75pt; border-image: none; width: 89pt; height: 24.9pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">2.994 pg/mL**</p>
            </td>
        </tr>
        <tr style="height: 24.9pt; mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
            <td valign="top" style="border-width: 0px 1pt 1pt; border-style: none solid solid; border-color: #000000 black black; padding: 3.75pt; border-image: none; height: 24.9pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">LBXSHBG</p>
            </td>
            <td valign="top" style="border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: black black black #000000; padding: 3.75pt; border-image: none; height: 24.9pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">SHBG (nmol/L)</p>
            </td>
            <td valign="top" style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; width: 89pt; height: 24.9pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="margin: 0in 0in 12pt; line-height: normal;">0.800 nmol/L&nbsp;</p>
            </td>
        </tr>
    </tbody>
</table>
<p style="margin: 0in 0.5in 0pt 0in; line-height: 15.95pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*Multiply by 0.0347
to convert to SI unit nmol/L
&nbsp;</p>
<p style="margin: 0in 0.5in 0pt 0in; line-height: 15.95pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Multiply by 3.67 to convert to
SI unit pmol/L&nbsp;</p>
<p style="line-height: 15.95pt; margin-top: 12pt; margin-right: 0.5in; margin-bottom: 12pt;"><b>Testosterone
regression equations to compar</b><b style="mso-bidi-font-weight: normal;">e 2013-14 and 2011-12 TST data:</b></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">A method validation (bridging) study was performed to compare results from a method change in 2013-2014 cycle for serum total testosterone. Total testosterone was performed with a HPLC tandem mass spectrometry method that only measured testosterone (TST) and was switched in mid-2013 to a HPLC tandem mass spectrometry method that measures TST and estradiol (EST) in the same analytical run. Randomly selected serum samples (n=139) from NHANES 2013-2014 participants were measured using both methods and the results were used to conduct the analysis. Data from the bridging study indicated <span>that on average, </span><span>testosterone</span><span> values measured using new method (TST plus EST) were 3.9% higher than values using old method (TST only) (p&lt;.0001), and </span><span>the correlation coefficient (<i>r</i>) between the measurements was 0.997.&nbsp; Regression analysis were performed using Analyse-It, v4.30.4.&nbsp; Given that the data showed proportional differences in variability, a weighted Deming regression was chosen to adjust the serum testosterone results (ng/mL).&nbsp; The forward and backward equations are below:</span></p>
<p style="margin: 0in 0.5in 12pt 139px; line-height: 15.95pt; text-indent: -67.5pt;">Forward: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y (TST plus EST) =
1.021 (95%CI: 1.007 to 1.0354) * X (TST only) + 0.182 (95%CI: 0.081 to 0.283) </p>
<p style="margin: 0in 0.5in 12pt 139px; line-height: 15.95pt; text-indent: -67.5pt;">Backward: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y (TST only) = 0.979
(95%CI: 0.966 to 0.992) * X (TST plus EST) -0.178 (95%CI: -0.277 to -0.079)</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">These regression equations should be used when examining trends of testosterone data across 2013-2014 and 2011-2012 cycles, or when combining the 2013-2014 data with the previous cycle.&nbsp; </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">As mentioned above, most of the 2013-2014 samples were measured using the TST plus EST method.&nbsp; Results in this 2013-2014 dataset from specimens analyzed using the TST only method were adjusted using the above forward regression equation.&nbsp; </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Please refer to the NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx" target="_blank">Analytic Guidelines</a> and the on-line NHANES <a href="https://www.cdc.gov/nchs/tutorials/">Tutorial</a> for further details on the use of sample weights and other analytic issues.</p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241-7.</li>
          <li>Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-44.</li>
          <li>Burger H.G., Dudley E.C., Robertson D.M., Dennerstein L.  Hormonal changes in the menopause transition.  Recent Prog Horm Res. (2002) 57:257-75.</li>
          <li>Caudill S.P., Schleicher R.L., Pirkle J.L., Multi-rule quality control for the age-related eye disease study. Statist. Med. (2008) 27(30):4094-40106.</li>
          <li>Davis S, Mirick DK, Stevens RG.  Night shift work, light at night, and risk of breast cancer.  J Natl Cancer Inst. (2001) Oct 17;93(20):1557-62.<br /></li>
          <li>Pugeat M., Crave J.C., Tourniaire J., Forest M.G. Clinical Utility of Sex Hormone-Binding Globulin Measurement.  Horm Res (1996) 45:148&ndash;155.</li>
          <li>Rosner W., Hryb D.J., Khan M.S., Nakhla A.M., Romas N.A.  Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane.  J Steroid Biochem Mol Biol. (1999) Apr-Jun;69(1-6):481-5</li>
          <li>Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart for quality control
in clinical chemistry. Clin Chem (1981) 27:493-501.</li>
          <li>Zhou H, Wang Y, Gatcombe M, Farris J, Botelho JC, Caudill SP,Vesper HW. Simultaneous measurement of total estradiol and testosterone in human serum by isotope dilution liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2017 Oct; 409(25):5943-5954. doi: 10.1007/s00216-017-0529-x. Epub 2017 Aug 11. PMID: 28801832; PMCID: PMC5693763.</li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXTST">LBXTST - Testosterone, total (ng/dL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXTST</dd>
            <dt>SAS Label: </dt>
            <dd>Testosterone, total (ng/dL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Testosterone, total (ng/dL)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0.41 to 1550</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">7559</td>
                <td class="values" align="right">7559</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">732</td>
                <td class="values" align="right">8291</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDTSTLC">LBDTSTLC - Testosterone comment code</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDTSTLC</dd>
            <dt>SAS Label: </dt>
            <dd>Testosterone comment code</dd>
            <dt>English Text: </dt>
            <dd class="info">Testosterone comment code</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">At or above the detection limit</td>
                <td class="values" align="right">7550</td>
                <td class="values" align="right">7550</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Below lower detection limit</td>
                <td class="values" align="right">9</td>
                <td class="values" align="right">7559</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">732</td>
                <td class="values" align="right">8291</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXEST">LBXEST - Estradiol (pg/mL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXEST</dd>
            <dt>SAS Label: </dt>
            <dd>Estradiol (pg/mL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Estradiol (pg/mL)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">2.117 to 1220</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">7275</td>
                <td class="values" align="right">7275</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">1016</td>
                <td class="values" align="right">8291</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDESTLC">LBDESTLC - Estradiol Comment Code</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDESTLC</dd>
            <dt>SAS Label: </dt>
            <dd>Estradiol Comment Code</dd>
            <dt>English Text: </dt>
            <dd class="info">Estradiol Comment Code</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">At or above the detection limit</td>
                <td class="values" align="right">6238</td>
                <td class="values" align="right">6238</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Below lower detection limit</td>
                <td class="values" align="right">1037</td>
                <td class="values" align="right">7275</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">1016</td>
                <td class="values" align="right">8291</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXSHBG">LBXSHBG - SHBG (nmol/L)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXSHBG</dd>
            <dt>SAS Label: </dt>
            <dd>SHBG (nmol/L)</dd>
            <dt>English Text: </dt>
            <dd class="info">Sex Hormone Binding Globulin (SHBG, nmol/L)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">5.18 to 1067</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">6578</td>
                <td class="values" align="right">6578</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">1713</td>
                <td class="values" align="right">8291</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDSHGLC">LBDSHGLC - SHBG Comment Code</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDSHGLC</dd>
            <dt>SAS Label: </dt>
            <dd>SHBG Comment Code</dd>
            <dt>English Text: </dt>
            <dd class="info">SHBG Comment Code</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">At or above the detection limit</td>
                <td class="values" align="right">6578</td>
                <td class="values" align="right">6578</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Below lower detection limit</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">6578</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">1713</td>
                <td class="values" align="right">8291</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>